Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D

, , , &
Journal of Law, Medicine and Ethics 50 (S2):47-54 (2022)
  Copy   BIBTEX

Abstract

The inclusion of antimicrobial resistance (AMR) and increased research and development (R&D) capabilities in the most recent outline of the World Health Organization’s (WHO’s) international pandemic instrument signals an opportunity to reshape pharmaceutical R&D system in favour of antimicrobial product development. This article explains why the current innovation ecosystem has disadvantaged the creation of antimicrobial products for human use. It also highlights how the COVID-19 pandemic experience can inform and stimulate international cooperation to implement innovative R&D incentives to bring new, life-saving antimicrobial products to the market.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2022.79

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,098

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Antimicrobial Resistance Must Be Included in the Pandemic Instrument to Ensure Future Global Pandemic Readiness.Shajoe J. Lake, Susan Rogers Van Katwyk & Steven J. Hoffman - 2022 - Journal of Law, Medicine and Ethics 50 (S2):9-16.
A Global Pandemic Treaty Must Address Antimicrobial Resistance.Lindsay A. Wilson, Susan Rogers Van Katwyk, Isaac Weldon & Steven J. Hoffman - 2021 - Journal of Law, Medicine and Ethics 49 (4):688-691.
Introduction: AMR Belongs in the Pandemic Instrument.Susan Rogers Van Katwyk & Kevin Outterson - 2022 - Journal of Law, Medicine and Ethics 50 (S2):6-8.
A Pandemic Instrument can Optimize the Regime Complex for AMR by Striking a Balance between Centralization and Decentralization.Isaac Weldon, Safaa Yaseen & Steven J. Hoffman - 2022 - Journal of Law, Medicine and Ethics 50 (S2):26-33.
Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals.J. Scott Weese, Guilherme Antonio Da Costa Junior, Bruno Gonzalez-Zorn, Laura Y. Hardefeldt, Jorge Matheu, Gerard Moulin, Stephen W. Page, Ruby Singh, Junxia Song & Olafur Valsson - 2022 - Journal of Law, Medicine and Ethics 50 (S2):55-63.
Adopting a Global AMR Target within the Pandemic Instrument Will Act as a Catalyst for Action.Susan Rogers Van Katwyk, Lindsay Wilson, Isaac Weldon, Steven J. Hoffman & Mathieu J. P. Poirier - 2022 - Journal of Law, Medicine and Ethics 50 (S2):64-70.
A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial Effectiveness.Isaac Weldon, Kathy Liddell, Susan Rogers Van Katwyk, Steven J. Hoffman, Timo Minssen, Kevin Outterson, Stephanie Palmer, A. M. Viens & Jorge Viñuales - 2022 - Journal of Law, Medicine and Ethics 50 (S2):17-25.
How law can help solve the collective action problem of antimicrobial resistance.Steven J. Hoffman, Reema Bakshi & Susan Rogers Van Katwyk - 2019 - Bioethics 33 (7):798-804.
Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union.Victor L. Van de Wiele, Adam Raymakers, Aaron S. Kesselheim & Benjamin N. Rome - 2023 - Journal of Law, Medicine and Ethics 51 (1):213-216.
A trade‐off: Antimicrobial resistance and COVID‐19.Tess Johnson - 2021 - Bioethics 1 (1):1-9.

Analytics

Added to PP
2023-03-10

Downloads
10 (#1,221,969)

6 months
8 (#415,167)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references